Robuta

https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01113 Enzalutamide before Surgery in Treating Patients with Kidney Cancer, the BARE Study - NCI Enzalutamide before Surgery in Treating Patients with Kidney Cancer, the BARE Study https://www.cancer.gov/about-cancer/treatment/drugs/enzalutamide Enzalutamide - NCI This page contains brief information about enzalutamide and a collection of links to more information about the use of this drug, research results, and ongoing... enzalutamidenci https://dukespace.lib.duke.edu/items/35b0cf70-f2d0-4f2e-b2f2-dba78f308359 Molecular determinants for enzalutamide-induced transcription in prostate cancer. Enzalutamide, a second-generation androgen receptor (AR) antagonist, has demonstrated clinical benefit in men with prostate cancer. However, it only provides a... moleculardeterminantsenzalutamideinducedtranscription https://pubmed.ncbi.nlm.nih.gov/25184630/ AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer Detection of AR-V7 in circulating tumor cells from patients with castration-resistant prostate cancer may be associated with resistance to enzalutamide and... arresistanceenzalutamideabirateroneprostate https://adisinsight.springer.com/drugsafety/803381836?error=cookies_not_supported&code=a334b9b7-a849-4fe8-9b60-69200665dc0f Abiraterone acetate/enzalutamide - AdisInsight A man in his early 60s [exact age at the time of reaction onset not stated] developed spinal epidural lipomatosis following treatment with abiraterone acetate abiraterone acetateenzalutamideadisinsight https://pmc.ncbi.nlm.nih.gov/articles/PMC5716891/ Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells - PMC Prostate cancer remains dependent on androgen receptor signaling even after castration. Aberrant androgen receptor signaling in castration resistant prostate... https://umu.diva-portal.org/smash/record.jsf?pid=diva2:1056647&language=sv Targeted suppression of AR-V7 using PIP5K1 alpha inhibitor overcomes enzalutamide resistance in... https://pmc.ncbi.nlm.nih.gov/articles/PMC12522525/ Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide... To evaluate the longitudinal transcriptomic changes that occurred over time in patients from the ENACT trial (ClinicalTrials.gov identifier: NCT02799745).... https://pubmed.ncbi.nlm.nih.gov/33705584/ Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world... Despite the common use of concomitant therapy in this real-world study, there was no difference in OS among mCRPC patients. A nonsignificant increased SRE risk... https://pubmed.ncbi.nlm.nih.gov/37285865/ Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-mdv3100-prostate-cancer-spread-not-responding-to-hormone-therapy-prevail A trial of enzalutamide for prostate cancer that has spread and is not responding to hormone... This trial is looking at a new drug called MDV3100 for prostate cancer that has spread to other parts of the body and is getting worse despite hormone https://www.cancerresearchuk.org/about-cancer/treatment/drugs/enzalutamide Enzalutamide | Cancer information | Cancer Research UK Enzalutamide is type of hormone therapy drug. It is a treatment for prostate cancer. Find out about how you have it and possible side effects. cancer informationenzalutamideresearchuk https://ce.icep.wisc.edu/human-oncology-journal-club-2020-22-/content/abiraterone-acetate-and-prednisolone-or-without-enzalutamide-high-risk-non-metastatic Abiraterone Acetate and Prednisolone with or without Enzalutamide for High-Risk Non-Metastatic... EvaluationClick here to complete the evaluation: https://ce.icep.wisc.edu/content/human-oncology-journal-club-2020-22-evaluation-18998 https://open.library.ubc.ca/soa/cIRcle/collections/facultyresearchandpublications/52383/items/1.0392543 Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate... Learning, knowledge, research, insight: welcome to the world of UBC Library, the second-largest academic research library in Canada. prostate cancerionizing radiationenzalutamideresistant https://experts.umn.edu/en/projects/a-phase-i1b-study-of-enzalutamide-in-combination-with-g/fingerprints/ A Phase I/1b Study of Enzalutamide in Combination with G - Fingerprint - Experts@Minnesota https://researchconnect.buffalo.edu/en/publications/linking-prostate-cancer-cell-ar-heterogeneity-to-distinct-castrat/ Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses -... prostate cancer https://pubmed.ncbi.nlm.nih.gov/40383194/ Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide... KEYNOTE-991 did not meet its primary endpoint and was stopped for futility. The addition of pembrolizumab to enzalutamide and ADT was associated with higher... pembrolizumabplusenzalutamideandrogendeprivation https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/trial-idasanutlin-abiraterone-enzalutamide-prostate-cancer-spread-madcap A trial of idasanutlin with abiraterone or enzalutamide for prostate cancer that has spread (MAdCaP) This trial looked at idasanutlin for prostate cancer that was no longer responding to hormone therapy and had spread to another part of the body. https://pubmed.ncbi.nlm.nih.gov/31329516/ ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo... Enzalutamide with ADT significantly reduced the risk of metastatic progression or death over time versus placebo plus ADT in men with mHSPC, including those...